Immunoadsorption can improve cardiac function in transplant candidates with non-ischemic dilated cardiomyopathy associated with diabetes mellitus
Authors:
- 1 May 2015
- journal article
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 18, 124-133
Abstract
No abstract availableKeywords
Funding Information
- Fresenius Medical Care GmbH
This publication has 25 references indexed in Scilit:
- Diabetic CardiomyopathyJournal of Cardiac Failure, 2010
- Effects of immunoadsorption and subsequent immunoglobulin G substitution on cardiopulmonary exercise capacity in patients with dilated cardiomyopathyAmerican Heart Journal, 2010
- Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Heart Transplant Report—2009The Journal of Heart and Lung Transplantation, 2009
- Sera from Patients with Type 2 Diabetes Contain Agonistic Autoantibodies Against G Protein-Coupled ReceptorsScandinavian Journal of Immunology, 2009
- Hemodynamic improvement and removal of autoantibodies against β1-adrenergic receptor by immunoadsorption therapy in dilated cardiomyopathyJournal of Autoimmunity, 2003
- Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathyJACC, 2000
- Removal of autoantibodies in dilated cardiomyopathy by immunoadsorptionInternational Journal of Cardiology, 1996
- Anti-β1-adrenoceptor autoantibodies with chronotropic activity from the serum of patients with dilated cardiomyopathy: Mapping of epitopes in the first and second extracellular loopsJournal of Molecular and Cellular Cardiology, 1995
- Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy.Journal of Clinical Investigation, 1993
- Immunologic studies of peripheral blood from patients with idiopathic dilated cardiomyopathyAmerican Heart Journal, 1986